Firgaira FA[au] - Search Results

Year	Number of Results
1979	2
1980	1
1981	3
1983	1
1984	1
1985	1
1986	1
1987	1
1989	1
1990	1
1992	1
1993	3
1994	1
1995	1
1996	1
1998	1
1999	2
2000	1
2002	1
2003	2
2023	0

1

Mitotic recombination is an important mutational event following oxidative damage.

Turner DR, Dreimanis M, Holt D, Firgaira FA, Morley AA. Turner DR, et al. Among authors: firgaira fa. Mutat Res. 2003 Jan 28;522(1-2):21-6. doi: 10.1016/s0027-5107(02)00194-x. Mutat Res. 2003. PMID: 12517408 Review.

2

Dihydropteridine reductase deficiency diagnosis by assays on peripheral blood-cells.

Firgaira FA, Cotton RG, Danks DM. Firgaira FA, et al. Lancet. 1979 Dec 15;2(8155):1260-3. doi: 10.1016/s0140-6736(79)92279-7. Lancet. 1979. PMID: 93181

3

Isolation and characterization of dihydropteridine reductase from human liver.

Firgaira FA, Cotton RG, Danks DM. Firgaira FA, et al. Biochem J. 1981 Jul 1;197(1):31-43. doi: 10.1042/bj1970031. Biochem J. 1981. PMID: 7317032 Free PMC article.

4

Isolation of fetal trophoblast cells from peripheral blood of pregnant women.

Mueller UW, Hawes CS, Wright AE, Petropoulos A, DeBoni E, Firgaira FA, Morley AA, Turner DR, Jones WR. Mueller UW, et al. Among authors: firgaira fa. Lancet. 1990 Jul 28;336(8709):197-200. doi: 10.1016/0140-6736(90)91731-o. Lancet. 1990. PMID: 1973769

5

Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis.

Seshadri R, Leong AS, McCaul K, Firgaira FA, Setlur V, Horsfall DJ. Seshadri R, et al. Among authors: firgaira fa. Int J Cancer. 1996 Apr 22;69(2):135-41. doi: 10.1002/(SICI)1097-0215(19960422)69:2<135::AID-IJC12>3.0.CO;2-8. Int J Cancer. 1996. PMID: 8608982 Free article.

6

Evidence for whole chromosome 6 loss and duplication of the remaining chromosome in acute lymphoblastic leukemia.

McEvoy CR, Morley AA, Firgaira FA. McEvoy CR, et al. Among authors: firgaira fa. Genes Chromosomes Cancer. 2003 Jul;37(3):321-5. doi: 10.1002/gcc.10214. Genes Chromosomes Cancer. 2003. PMID: 12759931

7

Frequency and genetic basis of MHC, beta-2-microglobulin and MEMO-1 loss of heterozygosity in sporadic breast cancer.

McEvoy CR, Seshadri R, Morley AA, Firgaira FA. McEvoy CR, et al. Among authors: firgaira fa. Tissue Antigens. 2002 Sep;60(3):235-43. doi: 10.1034/j.1399-0039.2002.600305.x. Tissue Antigens. 2002. PMID: 12445306

8

Human dihydropteridine reductase: a method for the measurement of activity in cultured cells, and its application to malignant hyperphenylalaninemia.

Firgaira FA, Cotton RG, Danks DM. Firgaira FA, et al. Clin Chim Acta. 1979 Jul 2;95(1):47-59. doi: 10.1016/0009-8981(79)90335-8. Clin Chim Acta. 1979. PMID: 41656

9

Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group.

Seshadri R, Firgaira FA, Horsfall DJ, McCaul K, Setlur V, Kitchen P. Seshadri R, et al. Among authors: firgaira fa. J Clin Oncol. 1993 Oct;11(10):1936-42. doi: 10.1200/JCO.1993.11.10.1936. J Clin Oncol. 1993. PMID: 8105035

10

Rapid detection of the factor V Leiden (1691 G > A) and haemochromatosis (845 G > A) mutation by fluorescence resonance energy transfer (FRET) and real time PCR.

Neoh SH, Brisco MJ, Firgaira FA, Trainor KJ, Turner DR, Morley AA. Neoh SH, et al. Among authors: firgaira fa. J Clin Pathol. 1999 Oct;52(10):766-9. doi: 10.1136/jcp.52.10.766. J Clin Pathol. 1999. PMID: 10674036 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results